caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1104183631

John ShenM.D.

Hematology-OncologyLos Angeles, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
89.3
Quality
80.6
Cost
73.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.60%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
1,005
Beneficiaries
—
Total drug cost
$7.2M
Distinct drugs
13
Brand share
56.0%
Top prescribed drugs
Abiraterone Acetate205 claims
Apalutamide177 claims
Prednisone145 claims
Darolutamide137 claims
Enzalutamide119 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$8K
Payment records
18
By payment type
Consulting Fee$8K
Food and Beverage$519
Education$118
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,415
Unique beneficiaries
—
Total services
8,446
Distinct HCPCS
25
Medicare payment
$310K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — top quintile (cohort median 4,173).